Extera unlocks shareholder value in promising international life science companies through interim senior management, focused consulting, and selective financial investment. Our team includes top industry managers backed by an extensive network of executive advisors.
Extera Advisory Services opens and expands the US and European markets for promising life science companies that seek industry partners, funds, and R&D expertise. Our engagements typically include flexible shared-upside models, ensuring comprehensive alignment of our incentives with our clients and their investors.
Extera Capital is selectively providing growth funding to medical and life science product stage companies that meet strict investment criteria. | |
|
